Abstract
In vitro bile salt binding equilibria and kinetic studies were performed with cholestyramine to determine how these factors influence bile sequestrant efficacy in vivo. Chloride ion at physiologic concentrations caused more than a twofold reduction in glycocholate (GCH) binding, compared to binding in the absence of salt, over a range of GCH concentrations and was also observed to displace bound GCH. In addition, chloride ion displaced from cholestyramine as a result of bile salt binding was measured using a chloride selective electrode, and the results show that bile salt binding is due to ion exchange. Comparison of the results of the equilibrium binding experiments to human data shows that the effect of anion binding competition alone cannot account for the lack of efficacy of cholestyramine. Consideration of other effects, such as additional binding competition or poor availability for binding, based on data from the literature, shows that adequate bile salt binding potential exists and that these interferences are not major factors influencing resin efficacy. In kinetic studies, both binding uptake of GCH and displacement of GCH from cholestyramine by chloride ion were relatively rapid, indicating that cholestyramine should equilibrate rapidly with bile salts in the GI tract. Based on these findings, it is suggested that the low efficacy of cholestyramine is a result mainly of its relatively poor ability to prevent bile salt reabsorption in the ileum.
Similar content being viewed by others
REFERENCES
T. A. Miettinen. Effects of neomycin alone and in combination with cholestyramine on serum cholesterol and fecal steroids in hypercholesterolemic subjects. J. Clin. Invest. 64:1485–1493 (1979).
Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251:365–374 (1984).
G. Oster and A. M. Epstein. Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. JAMA 258:2381–2387 (1987).
R. De Simone, F. Conti, M. R. Lovati, M. Sirtori, E. Cocuzza, and C. R. Sirtori. New microporous cholestyramine analog for treatment of hypercholesterolemia. J. Pharm. Sci. 67:1695–1698 (1978).
H. Toda, K. Kihara, M. Hashimoto, and S. Mizogami. Bile acid binding and hypocholesterolemic activity of a new anion exchange resin from 2-methylimidizole and epichlorohydrin. J. Pharm. Sci. 77:531–533 (1988).
W. T. Beher, G. J. Lin, K. K. Casazza, and J. Bertasius. Effects of anion-exchange polymers on bile acid metabolism in the rat. Atherosclerosis 16:169–174 (1972).
W. H. Johns and T. R. Bates. Quantification of the binding tendencies of cholestyramine. I. Effect of structure and added electrolyte on the binding of unconjugated and conjugated bile-salt anions. J. Pharm. Sci. 58:179–183 (1969).
F. Helferrich. Ion Exchange, McGraw-Hill, New York, 1962.
S. Buadvari (ed.). The Merck Index, 11th ed., Merck & Co., Rahway, NJ, 1989, p. 342.
J. T. Garbutt and T. J. Kenney. Effect of cholestyramine on bile acid metabolism in normal man. J. Clin. Invest. 51:2781–2789 (1972).
M. C. Carey, M. J. Armstrong, N. A. Mazer, H. Igimi, and G. Salvioli. Measurement of the hydrophillic-hydrophobic balance of bile salts: Correlation with physical-chemical interactions between membrane lipids and bile salt micelles. In G. Paumgartner, A. Stiehl, and W. Gerok (eds.), Bile Acids and Cholesterol in Health and Disease, MTP Press, Lancaster, PA, 1983, pp. 31–42.
T. C. Northfield and I. McColl. Postprandial concentrations of free and conjugated bile acids from the length of the normal human small intestine. Gut 14:513–518 (1973).
G. E. Boyd, J. Schubert, and A. W. Adamson. The exchange adsorption of ions from aqueous solutions by organic zeolites. I. Ion-exchange equilibria. J. Am. Chem. Soc. 69:2818–2829 (1947).
J. S. Fordtran and T. W. Locklear. Ionic constituents and osmolality of gastric and small-intestinal fluids after eating. Am. J. Digest. Dis. 11:503–521 (1966).
C. Lentner (ed.). Geigy Scientific Tables, Ciba-Geigy Limited, Basle, 1981, p. 147.
L. M. Hagerman, D. A. Julow, and D. L. Schneider. In vitro binding of mixed micellar solutions of fatty acids and bile salts by cholestyramine. Proc. Soc. Exp. Biol. Med. 143:89–92 (1973).
R. Kos, J. L. White, S. L. Hem, and M. T. Borin. Effect of competing anions on binding of bile salts by cholestyramine. Pharm. Res. 8:238–241 (1991).
W. H. Johns and T. R. Bates. Quantification of the binding tendencies of cholestyramine. II. Mechanism of the interaction with bile salt and fatty acid salt anions. J. Pharm. Sci. 59:329–333 (1970).
A. F. Hofmann and B. Borgstrom. Physico-chemical state of lipids in intestinal content during their digestion and absorption. Fed. Proc. 21:43–50 (1962).
A. F. Hofmann and B. Borgstrom. The intraluminal phase of fat digestion in man: The lipid content of the micellar and oil phases of intestinal contents. J. Clin. Invest. 43:247–257 (1964).
L. M. Hagerman and D. L. Schneider. Effect of cholestyramine on fecal bile salt excretion in rats fed diets containing mediumchain triglycerides or corn oil. Proc. Soc. Exp. Biol. Med. 143:93–96 (1973).
R. B. Zurier, S. A. Hashim, and T. B. Van Itallie. Effect of medium chain triglycerides on cholestyramine-induced steatorrhea in man. Gastroenterology 49:490–495 (1965).
G. W. Kuron, N. Grier, and J. W. Huff. The bile acid binding and hypercholesterolemic action of two water-soluble polymers. Atherosclerosis 37:353–360 (1980).
T. A. Miettinen. Mechanism of nonabsorbable lipid-lowering drugs. In Proc. Sixth Int. Congr. Pharmacol, Vol. 4, Finn. Pharmacol. Soc, Helsinki, 1975, pp. 149–158.
P. E. Luner. Ph.D. dissertation, University of Michigan, Ann Arbor, 1990, pp. 142–146.
S. Lindenbaum and T. Higuchi. Binding of bile acids to cholestyramine at gastric pH conditions. J. Pharm. Sci. 64:1887–1889 (1975).
G. L. Starobinets and I. F. Gleim. Ion exchange of weak organic electrolytes. Russ. J. Phys. Chem. 39:1166–1169 (1965).
Y. Farag and J. G. Nairn. Rate of release of organic carboxylic acids from ion-exchange resins. J. Pharm. Sci. 77:872–875 (1988).
J. Blanchard and J. G. Nairn. The binding of cholate and glycocholate anions by anion-exchanging resins. J. Phys. Chem. 72:1204–1208 (1968).
S.-D. Clas. Cellulose ionomers as cholesterol-lowering drugs. Polym. Preprints 29:438–439 (1988).
W. H. Johns and T. R. Bates. Quantification of the binding tendencies of cholestyramine. III. Rates of adsorption of conjugated bile salt anions onto cholestyramine as a function of added inorganic electrolyte concentration, temperature, and agitation intensity. J. Pharm. Sci. 59:788–793 (1970).
A. Billiau and J. Van den Bosch. The influence of cholestyramine on the intestinal absorption of glycocholic acid. Arch. Int. Pharmacodyn. 150:46–51 (1964).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Luner, P.E., Amidon, G.L. Equilibrium and Kinetic Factors Influencing Bile Sequestrant Efficacy. Pharm Res 9, 670–676 (1992). https://doi.org/10.1023/A:1015862329303
Issue Date:
DOI: https://doi.org/10.1023/A:1015862329303